Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem neuroimaging study in akinetic mutism
NL-OMON47472Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of zolpidem in akinetic mutism (AM), sponsored by Amsterdam University Medical Center. Primary endpoint: Functional change on neuroimaging and neurophysiology after zolpidem. Started Sep 2017; status: active, not recruiting.
02
Drugs
zolpidem
03
Conditions
akinetic mutism (AM)
Beyond the preview
Go deeper on NL-OMON47472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47472.